iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Shares Purchased by Captrust Financial Advisors

Captrust Financial Advisors increased its stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 3.5% in the 4th quarter, HoldingsChannel reports. The firm owned 5,025 shares of the company’s stock after buying an additional 171 shares during the quarter. Captrust Financial Advisors’ holdings in iShares U.S. Pharmaceuticals ETF were worth $330,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of the stock. Atala Financial Inc acquired a new position in iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at $25,000. Union Bancaire Privee UBP SA acquired a new position in iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at $42,000. Capital Analysts LLC raised its holdings in iShares U.S. Pharmaceuticals ETF by 41.8% in the 4th quarter. Capital Analysts LLC now owns 1,575 shares of the company’s stock valued at $104,000 after acquiring an additional 464 shares during the last quarter. Comerica Bank raised its holdings in iShares U.S. Pharmaceuticals ETF by 23.1% in the 4th quarter. Comerica Bank now owns 2,466 shares of the company’s stock valued at $162,000 after acquiring an additional 462 shares during the last quarter. Finally, Runnymede Capital Advisors Inc. acquired a new position in iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at $164,000.

iShares U.S. Pharmaceuticals ETF Stock Performance

Shares of IHE opened at $65.12 on Wednesday. The stock has a fifty day moving average of $65.85 and a two-hundred day moving average of $67.64. The company has a market capitalization of $560.03 million, a PE ratio of 23.46 and a beta of 0.63. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $58.97 and a fifty-two week high of $73.28.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.